{"retracted":false,"update":{"timestamp":1427760000000,"doi":"10.1007/s00277-015-2356-5","type":"correction"},"doi":"10.1007/s00277-014-2272-0","journal":"Annals of Hematology","publisher":"Springer Nature","title":"Erratum to: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib"}
